CHAD Therapeutics, Inc. boasts today that its SAGE Oxygen Therapeutic Device won the 2005 Medical Design Excellence Award.
Company describes its product:
— Oxygen delivery device that minimizes blood oxygen level fluctuations, resulting in better patient outcomes.
— Incorporates two programmable delivery settings for rest and activity requirements.
— Reduces the risk of desaturation by automatically adjusting flow rates based on movement.
— Allows the home care provider or patient to preset and lock prescribed delivery settings.
— S.M.A.R.T. Technology determines the optimum time to switch between settings based on duration of movement.
–Helps reduce the breathlessness associated with activity, resulting in greater ease of movement and increased compliance with rehab programs.
— Utilizes CHAD’s proven sensor technology to delivery pulsed oxygen at the optimum point in the inspiratory cycle while reducing oxygen waste.
— Reduces the need to switch to continuous flow during increased exertion.
— Easy-to-read liquid crystal display (LCD).
— Based on the best-selling OXYMATIC 400 Series conserver platform for a seamless transition from CHAD’s oxygen conserving devices.